Drug Discovery & Development
We advance discovery and evaluation of new drug candidates by providing products and services that complement your work and help you achieve results faster than ever before. Through the acquisition of Upstate, Chemicon and Linco, we now offer a suite of products that span the drug discovery pipeline from target identification to clinical studies. Our expert team of scientists and engineers understands the complexity of your discovery and development and can support you in these challenges. Your drive to discovery starts with Millipore.
Target Screening &
| Biomarker Immunoassays & Multiplexing |
Preclinical & Clinical Development Services | Safety & Toxicity
|
Product News & Releases
- New Magnetic Bead Format Improves Automation Compatibility of Multiplex Assays
- Getting a More Complete Understanding of Cellular Communication
- As GPCR Space Becomes More Crowded, Drug Makers Show Affinity for Non-traditional GPCR Binding Sites
- Millipore Corporation and CXR Biosciences Introduce Toxicity Reporter Assay Panel
Featured Products



